1. Distance to CAR‐T Treatment Center Does Not Impede Delivery.
- Author
-
Tan, Xiu Xia Sherry, Maltez, Melissa T., Mallick, Ranjeeta, Hamelin, Linda, McDiarmid, Sheryl, Cieniak, Carolina, Granger, Matthew, Bredeson, Christopher, Kennah, Michael, Atkins, Harold L., and Kekre, Natasha
- Subjects
- *
B cell lymphoma , *CHIMERIC antigen receptors , *HEALTH facilities , *OVERALL survival , *SURVIVAL rate - Abstract
ABSTRACT Background Methods Results Conclusion Chimeric antigen receptor T‐cell (CAR‐T) therapy has demonstrated remarkable efficacy in relapsed or refractory large B cell lymphoma, but real‐world evidence is needed to confirm safety and efficacy when facing the unique challenges of a wide geographical catchment area.We reviewed patients treated with commercially available CAR‐T at a medium‐sized single center in Canada (The Ottawa Hospital) between December 2020 and July 2022 (Canadian implementation started in 2020).Fifty‐one patients (59% male, median age 62) traveled a median distance of 655 km (range 3–3659) for treatment. Median time from apheresis to CAR‐T infusion was 36 days (range 26–81). With a median follow‐up of 383 days (95% CI: 333–480), median progression‐free survival (PFS) and overall survival (OS) were 257 days (95% CI: 92‐NE) and 422 days (95% CI: 106‐NE), respectively. The median PFS for out‐of‐province patients was 115 days (95% CI: 91‐NE) versus 280 days for in‐province patients (95% CI: 142‐NE), p = 0.12. Multivariate analysis demonstrated that distance from treatment center (p = 0.05) and refractory disease status (p = 0.003) were independently associated with shorter PFS. The time from the last disease progression to CAR‐T referral was longer for out‐of‐province patients, but there was no difference in the time of referral to CAR‐T consult, apheresis, or CAR‐T infusion between in‐province and out‐of‐province patients.Our results confirm that despite the complexity of CAR‐T therapy administration, Ottawa can effectively provide commercial CAR‐T therapy in a timely fashion for patients from across the country. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF